Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25928951 | 0.90 | AR (0.40) | ARSCN9A | |
| SCHEMBL25328182 | 0.87 | AR (0.42) | AR | |
| SCHEMBL31131388 | 0.87 | AR (0.40) | ARSCN9A | |
| SCHEMBL25936331 | 0.86 | AR (0.44) | ARSCN9A | |
| SCHEMBL25936546 | 0.86 | AR (0.44) | ARSCN9A | |
| SCHEMBL31476797 | 0.82 | AR (0.42) | AR | |
| SCHEMBL25328831 | 0.81 | AR (0.44) | AR | |
| SCHEMBL25329434 | 0.81 | AR (0.42) | AR | |
| SCHEMBL25329956 | 0.81 | AR (0.42) | ARSCN9A | |
| SCHEMBL31131387 | 0.81 | AR (0.42) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4466260-A1 | COMPOUNDS AND THEIR USE IN TREATING CANCER | Astrazeneca AB (SE) | 2024-11-27 | — | — | EP | disclosed |
| WO-2023139199-A1 | COMPOUNDS AND THEIR USE IN TREATING CANCER | ASTRAZENECA AB (SE) | 2023-07-27 | — | — | WO | disclosed |